Hudson Bay Capital Management
CRXTW

Hudson Bay Capital Management’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Hudson Bay Capital Management’s Portfolio CRXTW Stock Details CRXTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-233,226
Closed -$127K – 1203
2021
Q1 		$127K Buy
+233,226
New +$187K ﹤0.01% 803

Other funds holding CRXTW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Hudson Bay Capital Management's CRXTW Position: Q2 2021 in Review

Hudson Bay Capital Management sold out of Clarus Therapeutics Holdings, Inc. Warrants (CRXTW) in Q2 2021, closing a stake of 233,226 shares — an estimated $127K sold.

Hudson Bay Capital Management first reported a position in CRXTW in Q1 2021 and held it in 1 quarter. The position peaked at $127K in Q1 2021. 22 funds tracked by Wall St. Rank hold CRXTW as of Q2 2021.

  • Hudson Bay Capital Management reported no remaining Clarus Therapeutics Holdings, Inc. Warrants position as of Q2 2021 after selling out during the quarter.
  • Hudson Bay Capital Management sold 233,226 Clarus Therapeutics Holdings, Inc. Warrants shares in Q2 2021, an estimated $127K.
  • Hudson Bay Capital Management first reported a position in Clarus Therapeutics Holdings, Inc. Warrants in Q1 2021 and held it in 1 quarter.
  • Hudson Bay Capital Management's Clarus Therapeutics Holdings, Inc. Warrants position peaked at $127K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Warrants as of Q2 2021.

Based on Hudson Bay Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.